Geneos Wealth Management’s National Instruments Corp NATI Stock Holding History

Geneos Wealth Management’s Portfolio NATI Stock Details NATI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-300	Closed	-$9K	–	2692
2022 Q2	$9K	Hold	300	–	–	﹤0.01%	2017
2022 Q1	$12K	Hold	300	–	–	﹤0.01%	2029
2021 Q4	$13K	Hold	300	–	–	﹤0.01%	2091
2021 Q3	$12K	Hold	300	–	–	﹤0.01%	2165
2021 Q2	$12K	Sell	300 -299	-50%	-$12.6K	﹤0.01%	2148
2021 Q1	$24K	Sell	599 -66	-10%	-$2.9K	﹤0.01%	1989
2020 Q4	$13K	Buy	665 +365	+122%	+$13.6K	﹤0.01%	2128
2020 Q3	$10K	Hold	300	–	–	﹤0.01%	1963
2020 Q2	$11K	Hold	300	–	–	﹤0.01%	1901
2020 Q1	$9K	Hold	300	–	–	﹤0.01%	1873
2019 Q4	$12K	Hold	300	–	–	﹤0.01%	1915
2019 Q3	$12K	Hold	300	–	–	﹤0.01%	1828
2019 Q2	$12K	Hold	300	–	–	﹤0.01%	1856
2019 Q1	$13K	Hold	300	–	–	﹤0.01%	1763
2018 Q4	$13K	Hold	300	–	–	﹤0.01%	1706
2018 Q3	$14K	Hold	300	–	–	﹤0.01%	1736
2018 Q2	$12K	Hold	300	–	–	﹤0.01%	1660
2018 Q1	$15K	Hold	300	–	–	﹤0.01%	1517
2017 Q4	$12K	Hold	300	–	–	﹤0.01%	1583
2017 Q3	$12K	Buy	+300	New	+$12.2K	﹤0.01%	1531

Other funds holding NATI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geneos Wealth Management's NATI Position: Q3 2022 in Review

Geneos Wealth Management sold out of National Instruments Corp (NATI) in Q3 2022, closing a stake of 300 shares — an estimated $9K sold.

Geneos Wealth Management first reported a position in NATI in Q3 2017 and held it in 20 quarters. The position peaked at $24K in Q1 2021. 294 funds tracked by Wall St. Rank hold NATI as of Q3 2022.

Geneos Wealth Management reported no remaining National Instruments Corp position as of Q3 2022 after selling out during the quarter.
Geneos Wealth Management sold 300 National Instruments Corp shares in Q3 2022, an estimated $9K.
Geneos Wealth Management first reported a position in National Instruments Corp in Q3 2017 and held it in 20 quarters.
Geneos Wealth Management's National Instruments Corp position peaked at $24K in Q1 2021.
294 funds tracked by Wall St. Rank held National Instruments Corp as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.